Benzinga - Thu, 04 Mar 2021 11:10:08 -0400
Benzinga - Thu, 04 Mar 2021 08:47:47 -0400
Benzinga - Wed, 03 Mar 2021 08:08:25 -0400
Benzinga - Wed, 03 Mar 2021 04:43:35 -0400
Benzinga - Thu, 04 Feb 2021 13:04:57 -0400
load more
Sector: Health Care.Industry: Biotechnology
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-10
REV
Q4 2020Est.ActualSurprise
EPS-0.700-0.850 -0.1500
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
PASGPassage Bio2.06%1.1B

Passage Bio Company Questions & Answers

Q

How do I buy Passage Bio (PASG) stock?

A

You can purchase shares of Passage Bio (NASDAQ: PASG) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Passage Bio's (PASG) main competitors?

Q

What is the target price for Passage Bio?

A

The latest price target for Passage Bio (NASDAQ: PASG) was reported by Goldman Sachs on 2021-03-04. The analyst firm set a price target for 30.00 expecting PASG to rise to within 12 months (a possible 51.29% upside). 9 analyst firms have reported ratings in the last year.

Q

How much is Passage Bio (PASG) stock ?

A

The stock price for Passage Bio (NASDAQ: PASG) is $19.83 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Passage Bio (PASG) dividend?

A

There are no upcoming dividends for Passage Bio.

Q

When is Passage Bio (NASDAQ:PASG) reporting earnings?

A
Passage Bio’s Q1 earnings are confirmed from now on May 10, 2021.
Q

When is the upcoming split for PASG?

A

There is no upcoming split for Passage Bio.